Société Sucampo Pharmaceuticals, Inc.
Actions
US8649091068
Recherche biotechnologique et médicale
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 46 636 924 | 45 389 949 ( 97,33 %) | 227 266 ( 0,4873 %) | 97,33 % |
Coordonnées société
Sucampo Pharmaceuticals, Inc.
805 King Farm Boulevard Suite 550
20850, Rockville
+301-961-3400
http://sucampo.comSociétés du groupe
Nom | Catégorie et Secteur |
---|---|
Sucampo Pharma LLC
Sucampo Pharma LLC Miscellaneous Commercial ServicesCommercial Services Sucampo Pharma LLC engages in the pharmaceutical product development. It develops the naturally occurring compound prostones, including lubiprostone under the brand Amitiza, which is used for the treatment of chronic constipation, chronic idiopathic constipation (CIC) in adults, and irritable bowel syndrome with constipation (IBS-C). The company is headquartered in Osaka, Japan. |
Miscellaneous Commercial Services
|
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
-3,30 % | 102 Md | |
+1,79 % | 96,07 Md | |
-1,46 % | 21,66 Md | |
-18,35 % | 20,77 Md | |
-7,91 % | 18,53 Md | |
-40,31 % | 16,91 Md | |
-26,84 % | 13,79 Md | |
+0,59 % | 13,33 Md | |
+20,86 % | 10,94 Md |